• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.40% Nasdaq Down 0.10%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    11.11 Up 0.09(0.82%) 4:00PM EDT
    |After Hours : 10.97 Down 0.14 (1.26%) 4:00PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:11.02
    Open:11.04
    Bid:11.03 x 500
    Ask:11.04 x 1400
    1y Target Est:23.90
    Beta:5.64
    Next Earnings Date: 4-May-15KERX Earnings announcement
    Day's Range:10.58 - 11.36
    52wk Range:10.58 - 18.48
    Volume:1,994,258
    Avg Vol (3m):1,621,520
    Market Cap:1.15B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 0.82%1.15B
    BAXDown 0.20%38.17B
    SHPGDown 0.44%48.49B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):105.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.95
    Quarterly EPS Est (Mar-15) :-0.30
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback